These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
60 related articles for article (PubMed ID: 19816013)
21. Randomized study on the conversion of treatment with cyclosporine to azathioprine or mycophenolate mofetil followed by dose reduction. Smak Gregoor PJ; van Gelder T; van Besouw NM; van der Mast BJ; IJzermans JN; Weimar W Transplantation; 2000 Jul; 70(1):143-8. PubMed ID: 10919591 [TBL] [Abstract][Full Text] [Related]
22. The use of tacrolimus as induction and maintenance immunosuppression in renal cadaveric transplant recipients over the age of 60. Xenos EX; Ciancio G; Burke GW; Roth D; Miller J Clin Transplant; 1997 Oct; 11(5 Pt 2):497-9. PubMed ID: 9361949 [TBL] [Abstract][Full Text] [Related]
23. Cancer Screening of Renal Transplant Patients Undergoing Long-Term Immunosuppressive Therapy. Demir T; Ozel L; Gökçe AM; Ata P; Kara M; Eriş C; Özdemir E; Titiz MI Transplant Proc; 2015 Jun; 47(5):1413-7. PubMed ID: 26093731 [TBL] [Abstract][Full Text] [Related]
24. CMV infections after two doses of daclizumab versus thymoglobulin in renal transplant patients receiving mycophenolate mofetil, steroids and delayed cyclosporine A. Abou-Ayache R; Büchler M; Lepogamp P; Westeel PF; Le Meur Y; Etienne I; Lobbedez T; Toupance O; Caillard S; Goujon JM; Bergougnoux L; Touchard G Nephrol Dial Transplant; 2008 Jun; 23(6):2024-32. PubMed ID: 18199693 [TBL] [Abstract][Full Text] [Related]
33. CAPD--a risk factor in renal transplantation? ARF after transplantation. Lambert MC; Bernaert P; Vijt D; de Smet R; Lameire N Perit Dial Int; 1996; 16 Suppl 1():S495-8. PubMed ID: 8728255 [No Abstract] [Full Text] [Related]
34. Urinary mutagenic activity after different immunosuppressive protocols in renal transplant patients. Fracasso ME; Barba A; Tessari G; Gasperini S; Brunello F Mutat Res; 1993 Dec; 319(4):279-83. PubMed ID: 7504201 [TBL] [Abstract][Full Text] [Related]
35. Pharmacodynamic parameters of immunosuppressive drugs are not correlated with age, duration of dialysis, percentage of lymphocytes or lymphocyte stimulation index in renal transplant recipients. Sugiyama K; Isogai K; Toyama A; Satoh H; Saito K; Nakagawa Y; Tasaki M; Takahashi K; Saito N; Hirano T Biol Pharm Bull; 2008 Nov; 31(11):2146-9. PubMed ID: 18981589 [TBL] [Abstract][Full Text] [Related]
36. Long-term genotoxic effects of immunosuppressive drugs on lymphocytes of kidney transplant recipients. Lizotti Cilião H; Batista de Oliveira Camargo-Godoy R; Mazzaron Barcelos GR; Zanuto A; Daher Alvares Delfino V; de Syllos Cólus IM Mutat Res Genet Toxicol Environ Mutagen; 2016 Aug; 806():47-52. PubMed ID: 27476335 [TBL] [Abstract][Full Text] [Related]
37. Effect of immunosuppression on damage, leukocyte infiltration, and regeneration after severe warm ischemia/reperfusion renal injury. De Greef KE; Ysebaert DK; Vercauteren SR; Chapelle T; Roeyen G; Bosmans JL; Verpooten GA; De Broe ME Transplant Proc; 2002 May; 34(3):791-4. PubMed ID: 12034184 [No Abstract] [Full Text] [Related]
38. Effect of ciclosporin on triglyceridemia in long-term renal transplant recipients. Verzola A; Bedani PL; Gilli P Nephron; 1999 Feb; 81(2):240-1. PubMed ID: 9933763 [No Abstract] [Full Text] [Related]
39. Influence of kidney or heart transplantation on the urinary excretion of epidermal growth factor. Amado JA; De-Francisco AL; Botana MA; Pesquera C; Vázquez-de-Prada JA; Arias M Transpl Int; 1994; 7(2):127-30. PubMed ID: 8179800 [TBL] [Abstract][Full Text] [Related]